Publications by authors named "Kerry J Savage"

100Publications

Evaluation of the discussion of late effects and screening recommendations in survivors of adolescent and young adult (AYA) lymphoma.

J Cancer Surviv 2020 Aug 6. Epub 2020 Aug 6.

Department of Radiation Oncology, British Columbia (BC) Cancer, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11764-020-00922-7DOI Listing
August 2020

Long-term outcomes for patients with limited-stage follicular lymphoma: update of a population-based study.

Blood 2020 Aug;136(8):1006-1010

Department of Medical Oncology, British Columbia Cancer, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.2019004588DOI Listing
August 2020

Validation of a simplified international prognostic score (IPS-3) in patients with advanced-stage classic Hodgkin lymphoma.

Br J Haematol 2020 Apr 10;189(1):122-127. Epub 2019 Dec 10.

Department of Medical Oncology, British Columbia Cancer, Centre for Lymphoid Cancer, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16293DOI Listing
April 2020

Keeping Our Finger on the Pulse: Reaffirming the Role of Radiation Therapy in the Curative Management of Early Stage Follicular Lymphoma.

Int J Radiat Oncol Biol Phys 2019 11 26;105(3):459-465. Epub 2019 Jun 26.

Centre for Lymphoid Cancer and the Department of Medical Oncology, BC Cancer, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2019.06.2505DOI Listing
November 2019

Outcome of patients with relapsed or refractory anaplastic large cell lymphoma who have failed brentuximab vedotin.

Hematol Oncol 2019 Feb 23;37(1):35-38. Epub 2018 Oct 23.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hon.2560
Publisher Site
http://dx.doi.org/10.1002/hon.2560DOI Listing
February 2019

Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial.

J Clin Oncol 2018 05 27;36(14):1428-1439. Epub 2018 Mar 27.

Philippe Armand and Margaret A. Shipp, Dana-Farber Cancer Institute, Boston, MA; Andreas Engert, University Hospital of Cologne, Cologne, Germany; Anas Younes, Memorial Sloan Kettering Cancer Center, New York, NY; Michelle Fanale, University of Texas MD Anderson Cancer Center, Houston, TX; Armando Santoro, Humanitas Cancer Center, Humanitas University, Milan; Pier Luigi Zinzani, Institute of Hematology "L. e A. Seràgnoli," University of Bologna, Bologna, Italy; John M. Timmerman, University of California Los Angeles Medical Center, Los Angeles, CA; Graham P. Collins, Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford, United Kingdom; Radhakrishnan Ramchandren, Barbara Ann Karmanos Cancer Institute, Detroit, MI; Jonathon B. Cohen, Winship Cancer Institute, Emory University, Atlanta, GA; Jan Paul De Boer, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands, on behalf of Lunenburg Lymphoma Phase I/II Consortium; John Kuruvilla, University of Toronto and Princess Margaret Cancer Centre, Toronto, Ontario; Kerry J. Savage, BC Cancer Agency, Vancouver, British Columbia, Canada; Marek Trneny, Charles University, General Hospital in Prague, Prague, Czech Republic; Kazunobu Kato, Anne Sumbul, and Benedetto Farsaci, Bristol-Myers Squibb, Princeton, NJ; and Stephen M. Ansell, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.0793DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075855PMC
May 2018

Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.

J Clin Oncol 2018 04 2;36(10):942-950. Epub 2018 Feb 2.

Margaretha G.M. Roemer, Robert A. Redd, Fathima Zumla Cader, Christine J. Pak, Sara Abdelrahman, Jing Ouyang, Philippe Armand, Donna S. Neuberg, and Margaret A. Shipp, Dana-Farber Cancer Institute; Geraldine S. Pinkus, Azra H. Ligon, and Scott J. Rodig, Brigham and Women's Hospital, Boston, MA; Margaretha G.M. Roemer, VU University Medical Center; Jan Paul De Boer, Antoni van Leeuwenhoek Hospital, Lunenburg Phase I/II Consortium, Amsterdam, the Netherlands; Stephanie Sasse, University Hospital of Cologne, Cologne, Germany; Anas Younes, Memorial Sloan Kettering Cancer Center, New York, NY; Michelle Fanale, University of Texas MD Anderson Cancer Center, Houston, TX; Armando Santoro, Humanitas University, Rozzano, Milan; Pier Luigi Zinzani, University of Bologna, Bologna, Italy; John Timmerman, University of California, Los Angeles Medical Center, Los Angeles, CA; Graham P. Collins, Churchill Hospital, Oxford, United Kingdom; Radhakrishnan Ramchandren, Barbara Ann Karmanos Cancer Institute, Detroit, MI; Jonathon B. Cohen, Emory University, Atlanta, GA; John Kuruvilla, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Kerry J. Savage, British Columbia Cancer Agency Center for Lymphoid Cancer, Vancouver, British Columbia, Canada; Marek Trneny, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic; Stephen Ansell, Mayo Clinic, Rochester, MN; and Kazunobu Kato, Benedetto Farsaci, and Anne Sumbul, Bristol-Myers Squibb, Princeton, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.3994DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877802PMC
April 2018

The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies.

Blood Rev 2018 05 20;32(3):249-255. Epub 2017 Dec 20.

Department of Lymphoid Cancer Research, BC Cancer Agency, Vancouver, BC, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0268960X173006
Publisher Site
http://dx.doi.org/10.1016/j.blre.2017.12.001DOI Listing
May 2018

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.

N Engl J Med 2018 01 10;378(4):331-344. Epub 2017 Dec 10.

From the University of British Columbia and the Department of Medical Oncology, British Columbia Cancer Agency Centre for Lymphoid Cancer, Vancouver, Canada (J.M.C., K.J.S.); the Department of Hematology, Jagiellonian University, Krakow (W.J.), the Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw (E.L.-M.), the Department of Hematology and Transfusion Medicine, Center of Postgraduate Medical Education, Warsaw (E.L.-M.), the Department of Experimental Hematology, Medical University of Lodz, Lodz (P.S.), and the Department of Lymphoid Malignancy, the Maria Sklodowska-Curie Memorial Institute and Oncology Center, Warsaw (J.W.) - all in Poland; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (D.J.S., A.Y.); the Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN (S.M.A.); the Division of Hematology and Oncology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea (W.S.K.); Research Innovation and Statistics, Antoine-Lacassagne Cancer Center, Nice, France (A.G.); Petrov Research Institute of Oncology, St. Petersburg, Russia (S.A.); the Department of Hematology, Faculty of Medicine, University of Debrecen, Debrecen (Á.I.), and the Department of Hematology, National Institute of Oncology, Budapest (A.R.) - both in Hungary; the Department of Advanced Biomedical Science, Federico II University Hospital, Naples (M.P.), and the Institute of Hematology Seràgnoli, University of Bologna, Bologna (P.L.Z.) - both in Italy; the Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston (Y.O.); John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ (T.F.); the Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis (N.L.B.); the Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA (R.C.); the Department of Hematology-Oncology, Barbara Ann Karmanos Cancer Center, Detroit (R.R.); Gastrointestinal and Lymphoma Unit, The Royal Marsden NHS Foundation Trust, Sutton (D.C.), and the Department of Medical Oncology, University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester (J.R.) - both in the United Kingdom; the Department of Clinical Development, Seattle Genetics, Bothell, WA (N.C.J., E.S.); and Oncology Clinical Research (J.S., H.A.J., D.H.) and Global Biostatistics (R.L.), Millennium Pharmaceuticals, Cambridge, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1708984DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819601PMC
January 2018

Secondary CNS relapse in diffuse large B-cell lymphoma: defining high-risk patients and optimization of prophylaxis strategies.

Authors:
Kerry J Savage

Hematology Am Soc Hematol Educ Program 2017 12;2017(1):578-586

Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2017.1.578DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142549PMC
December 2017

International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell Lymphoma.

J Clin Oncol 2017 Dec 26;35(36):4019-4026. Epub 2017 Oct 26.

Matthew J. Maurer, N. Nora Bennani, Stephen M. Ansell, James R. Cerhan, and Andrew L. Feldman, Mayo Clinic, Rochester, MN; Fredrik Ellin, Kalmar County Hospital, Kalmar; Fredrik Ellin and Thomas Relander, Lund University; Mats Jerkeman and Thomas Relander, Skåne University Hospital, Lund; Karin E. Smedby, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden; Line Srour, Joseph M. Connors, Graham W. Slack, and Kerry J. Savage, Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, British Columbia, Canada; and Brian K. Link, University of Iowa Hospitals and Clinics, Iowa City, IA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.8195DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736237PMC
December 2017

Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma.

J Clin Oncol 2017 Nov 12;35(32):3722-3733. Epub 2017 Sep 12.

Fong Chun Chan, Anja Mottok, Alina S. Gerrie, Maryse Power, Kerry J. Savage, Sohrab P. Shah, Joseph M. Connors, Randy D. Gascoyne, David W. Scott, and Christian Steidl, British Columbia Cancer Agency; Fong Chun Chan, Anja Mottok, Sohrab P. Shah, and Christian Steidl, University of British Columbia, Canada; Marcel Nijland, Arjan Diepstra, and Anke van den Berg, University Medical Center Groningen, Groningen, the Netherlands; and Peter Kamper, Francesco d'Amore, Alexander Lindholm d'Amore, and Stephen Hamilton-Dutoit, Aarhus University Hospital, Aarhus, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.7925DOI Listing
November 2017

Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Review of Current Disease Understanding and Therapeutic Approaches.

Hematol Oncol Clin North Am 2017 04;31(2):189-207

Department of Medical Oncology, British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, BC V5Z 4E6, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2016.11.009DOI Listing
April 2017

The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy.

Eur J Cancer 2017 04 23;75:195-203. Epub 2017 Feb 23.

Department of Haematology, Peter MacCallum Cancer Centre and University of Melbourne, 305 Grattan Street, Melbourne VIC 3000, Australia; Department of Hematology, Sir Charles Gairdner Hospital and Pathwest Laboratory Medicine, Hospital Ave, Nedlands WA 6009, Australia; University of Western Australia, 35 Stirling Hwy, Crawley, WA 6009, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.12.029DOI Listing
April 2017

Ventricular arrhythmias and sudden death in patients taking ibrutinib.

Blood 2017 05 21;129(18):2581-2584. Epub 2017 Feb 21.

Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-10-742437DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219062PMC
May 2017

Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis.

J Clin Oncol 2017 Jan 7;35(2):226-235. Epub 2016 Nov 7.

Sandra P. D'Angelo, Alexander N. Shoushtari, and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; James Larkin, Royal Marsden Hospital, London; Paul Lorigan, University of Manchester, Manchester, United Kingdom; Jeffrey A. Sosman, Vanderbilt University Medical Center, Nashville, TN; Celeste Lebbé, Saint-Louis Hospital, Institut National de la Santé et de la Recherche Médicale U976, Université Paris Diderot, Paris; Julie Charles, Grenoble University Hospital, Grenoble Alps University, Grenoble, France; Benjamin Brady, Cabrini Health, Melbourne, Australia; Bart Neyns, Universitair Ziekenhuis Brussel, Brussels, Belgium; Henrik Schmidt, Århus University, Åarhus, Denmark; Jessica C. Hassel, University Hospital Heidelberg, Heidelberg; Peter Mohr, Elbe Kliniken Buxtehude, Buxtehude; Martin Kaatz, SRH Waldklinikum Gera, University Hospital Jena, Jena, Germany; F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Kerry J. Savage, BC Cancer Agency, University of British Columbia, Vancouver; Wilson H. Miller Jr, Lady Davis Institute and Jewish General Hospital, McGill University, Montreal, Canada; Ivan Marquez-Rodas, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; Jeffrey S. Weber, Moffitt Cancer Center, Tampa, FL; and Mary Ruisi and Joel Jiang, Bristol-Myers Squibb, Princeton, NJ.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.67.9258
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.67.9258DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559888PMC
January 2017

Defining the clonality of peripheral T cell lymphomas using RNA-seq.

Bioinformatics 2017 04;33(8):1111-1115

Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia V5Z 1L3, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/bioinformatics/btw810DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408843PMC
April 2017

Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.

Int J Radiat Oncol Biol Phys 2017 01 13;97(1):35-41. Epub 2016 Oct 13.

Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2016.10.004DOI Listing
January 2017

Central Nervous System Prophylaxis for Aggressive B-cell Lymphoma: Who, What, and When?

Hematol Oncol Clin North Am 2016 Dec;30(6):1277-1291

Department of Medical Oncology, British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://repositori.upf.edu/bitstream/handle/10230/26255/gonza
Web Search
http://www.researchgate.net/profile/Leo_Gordon2/publication/
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S088985881630096
Publisher Site
http://dx.doi.org/10.1016/j.hoc.2016.07.008DOI Listing
December 2016

Nivolumab in the Treatment of Refractory Pediatric Hodgkin Lymphoma.

J Pediatr Hematol Oncol 2017 07;39(5):e263-e266

*Faculty of Medicine †Department of Radiology Divisions of ‡Anatomic Pathology ∥Hematology/Oncology/Bone Marrow Transplantation, British Columbia Children's Hospital §Centre for Lymphoid Cancer, British Columbia Cancer Agency ¶Michael Cuccione Childhood Cancer Research Program, Child & Family Research Institute, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00043426-201707000-0002
Publisher Site
http://dx.doi.org/10.1097/MPH.0000000000000703DOI Listing
July 2017

Immune checkpoint inhibitors in Hodgkin and non-Hodgkin lymphoma: how they work and when to use them.

Expert Rev Hematol 2016 11 17;9(11):1007-1009. Epub 2016 Oct 17.

a Centre for Lymphoid Cancer , British Columbia Cancer Agency , British Columbia , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2016.1242404DOI Listing
November 2016

Outcome of primary cutaneous anaplastic large cell lymphoma: a 20-year British Columbia Cancer Agency experience.

Br J Haematol 2017 Jan 21;176(2):234-240. Epub 2016 Oct 21.

Department of Medical Oncology, Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14404DOI Listing
January 2017

Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era.

Br J Haematol 2017 Jan 14;176(2):210-221. Epub 2016 Oct 14.

Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14392DOI Listing
January 2017

Leukocytoclastic vasculitis following lenalidomide during the treatment of follicular lymphoma.

Leuk Lymphoma 2017 03 25;58(3):711-714. Epub 2016 Aug 25.

a Division of Medical Oncology , BC Cancer Agency , Vancouver , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1204657DOI Listing
March 2017

Nodular lymphocyte-predominant Hodgkin lymphoma.

Semin Hematol 2016 Jul 13;53(3):190-202. Epub 2016 May 13.

MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2016.05.009DOI Listing
July 2016

Site of central nervous system (CNS) relapse in patients with diffuse large B-cell lymphoma (DLBCL) by the CNS-IPI risk model.

Br J Haematol 2017 11 22;179(3):508-510. Epub 2016 Jul 22.

Centre for Lymphoid Cancer and Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14229DOI Listing
November 2017

CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP.

J Clin Oncol 2016 09 5;34(26):3150-6. Epub 2016 Jul 5.

Norbert Schmitz, Maike Nickelsen, and Bertram Glass, Asklepios Hospital St Georg, Hamburg; Samira Zeynalova, Marita Ziepert, and Markus Loeffler, University of Leipzig, Leipzig; Michael Pfreundschuh, Saarland University Medical School, Homburg, Germany; Roopesh Kansara, Diego Villa, Laurie H. Sehn, David W. Scott, Randy D. Gascoyne, Joseph M. Connors, and Kerry J. Savage, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.6520DOI Listing
September 2016

Evaluation of the Risk of Relapse in Classical Hodgkin Lymphoma at Event-Free Survival Time Points and Survival Comparison With the General Population in British Columbia.

J Clin Oncol 2016 07 6;34(21):2493-500. Epub 2016 Jun 6.

Greg Hapgood, Laurie H. Sehn, Diego Villa, Richard Klasa, Alina S. Gerrie, Tamara Shenkier, David W. Scott, Randy D. Gascoyne, Graham W. Slack, Joseph M. Connors, and Kerry J. Savage, British Columbia Cancer Agency Centre for Lymphoid Cancer; Yvonne Zheng, Cancer Surveillance and Outcomes, Population Oncology; Christina Parsons, James Morris, and Tom Pickles, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.4194DOI Listing
July 2016

Comprehensive characterization of programmed death ligand structural rearrangements in B-cell non-Hodgkin lymphomas.

Blood 2016 09 7;128(9):1206-13. Epub 2016 Jun 7.

Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-11-683003DOI Listing
September 2016

Randomized, Double-Blind, Phase III Trial of Enzastaurin Versus Placebo in Patients Achieving Remission After First-Line Therapy for High-Risk Diffuse Large B-Cell Lymphoma.

J Clin Oncol 2016 07 23;34(21):2484-92. Epub 2016 May 23.

Michael Crump, Princess Margaret Cancer Centre, Toronto, Ontario; Kerry J. Savage, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Sirpa Leppä, Helsinki University Hospital Cancer Center, Helsinki, Finland; Luis Fayad, The University of Texas MD Anderson Cancer Center, Houston, TX; Frederick Schnell, Central Georgia Cancer Care, Macon, GA; Robert Rifkin, US Oncology Research Network and Rocky Mountain Cancer Centers, Denver, CO; Lauren Pinter-Brown, University of California at Los Angeles, Santa Monica, CA; Sonali Smith, University of Chicago, Chicago, IL; Eric D. Hsi, Cleveland Clinic, Cleveland, OH; Tuan Nguyen, Peipei Shi, Marjo Hahka-Kemppinen, Don Thornton, and Boris Lin, Eli Lilly and Company, Indianapolis, IN; Brad Kahl, University of Wisconsin, Madison, WI; Thomas Habermann, Mayo Clinic Cancer Research Consortium, Rochester, NY; Je Jung Lee, Chonnam National University Hwasun Hospital, Gwangju, South Korea; Alice Di Rocco, Sapienza University, Rome, Italy; Michinori Ogura, Tokai Central Hospital, Kakamigahara; Kensei Tobinai, National Cancer Center Hospital, Tokyo, Japan; Hans Hagberg, Akademiska Sjukhuset, Onkologkliniken, Uppsala, Sweden; Andreas Mackensen, University of Erlangen, Erlangen; Norbert Schmitz, Asklepios Klinik St Georg, Hamburg, Germany; Fritz Offner, University of Gent, Gent, Belgium; and Su-Peng Yeh, China Medical University Hospital, Taichung, Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.7171DOI Listing
July 2016

Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL.

Blood 2016 05 1;127(18):2182-8. Epub 2016 Feb 1.

Department of Pathology and Laboratory Medicine, Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-10-676700DOI Listing
May 2016

Rituximab with high-dose methotrexate in primary central nervous system lymphoma.

Am J Hematol 2015 Dec 17;90(12):1149-54. Epub 2015 Nov 17.

Centre for Lymphoid Cancer and Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.24204
Publisher Site
http://dx.doi.org/10.1002/ajh.24204DOI Listing
December 2015

Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies.

J Clin Oncol 2015 Sep 3;33(26):2848-56. Epub 2015 Aug 3.

David W. Scott, Anja Mottok, Daisuke Ennishi, Pedro Farinha, Susana Ben-Neriah, Robert Kridel, Garrett S. Barry, Christoffer Hother, Pau Abrisqueta, Merrill Boyle, Barbara Meissner, Adele Telenius, Kerry J. Savage, Laurie H. Sehn, Graham W. Slack, Christian Steidl, Joseph M. Connors, and Randy D. Gascoyne, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; George W. Wright and Louis M. Staudt, National Cancer Institute, Bethesda, MD; and Lisa M. Rimsza, University of Arizona, Tucson, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.2383DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554747PMC
September 2015

X. Challenges and future directions in peripheral T-cell lymphoma.

Hematol Oncol 2015 Jun;33 Suppl 1:56-61

Center for Lymphoid Cancer, British Columbia Cancer Agency and Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2218DOI Listing
June 2015

Impact of time from diagnosis to initiation of curative chemotherapy on survival of patients with diffuse large B-cell lymphoma.

Leuk Lymphoma 2016 Feb 19;57(2):276-282. Epub 2015 Jun 19.

d Division of Medical Oncology, University of British Columbia, and the British Columbia Cancer Agency Centre for Lymphoid Cancer , Vancouver , BC , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1055480DOI Listing
February 2016

The biology and management of systemic anaplastic large cell lymphoma.

Blood 2015 Jul 13;126(1):17-25. Epub 2015 Apr 13.

Centre for Lymphoid Cancer, Department of Medical Oncology, British Columbia Cancer Agency and Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-10-567461DOI Listing
July 2015

Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia.

Br J Haematol 2015 May 8;169(4):520-7. Epub 2015 Apr 8.

Department of Medical Oncology, British Columbia Cancer Agency - Vancouver Island Centre, Victoria, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13320DOI Listing
May 2015

A roadmap for discovery and translation in lymphoma.

Blood 2015 Mar;125(13):2175-7

Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-01-623777DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375113PMC
March 2015

Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis.

Blood 2014 Jun 8;123(23):3567-73. Epub 2014 Apr 8.

Centre for Lymphoid Cancer and Department of Medical Oncology, British Columbia Cancer Agency and the University of British Columbia, Vancouver, BC, Canada;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-12-541078DOI Listing
June 2014

Effect of place of residence and treatment on survival outcomes in patients with diffuse large B-cell lymphoma in British Columbia.

Oncologist 2014 Mar 25;19(3):283-90. Epub 2014 Feb 25.

Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Leukemia/Bone Marrow Transplantation Program of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958457PMC
March 2014

Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma.

Nat Genet 2014 Apr 16;46(4):329-35. Epub 2014 Feb 16.

1] Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, British Columbia, Canada. [2] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.2900DOI Listing
April 2014

The problem with cyclophosphamide, doxorubicin, vincristine and prednisone for the treatment of peripheral T-cell lymphoma.

Leuk Lymphoma 2014 Apr 28;55(4):727-9. Epub 2014 Jan 28.

Medical Oncology, British Columbia Cancer Agency , Vancouver, BC , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.858154DOI Listing
April 2014

Modern management of lymphocyte-predominant Hodgkin lymphoma.

Br J Haematol 2013 May 8;161(3):316-29. Epub 2013 Feb 8.

Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12244DOI Listing
May 2013